Endocrine abnormalities in patients with central serous chorioretinopathy

Ophthalmology

Volumn 110, Issue 4, 2003, Pages 698-703

  Haimovici, Robert ^a   Rumelt, Shimon ^a,b   Melby, James ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WESTERN GALILEE HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; GLUCOCORTICOID; MINERALOCORTICOID; TESTOSTERONE; THYROTROPIN;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD RETINA BARRIER; CATECHOLAMINE RELEASE; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENDOCRINE DISEASE; FEMALE; HUMAN; LABORATORY TEST; MALE; MENTAL STRESS; METABOLIC REGULATION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DETACHMENT;

EID: 0037397040     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01975-9     Document Type: Article

References (61)

1. Guyer DR, Yannuzzi LA, Slakter JS, et al. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994;112:1057-62.
2. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium II. Idiopathic central serous choroidopathy. Am J Ophthalmol 1967;63:587-615.
3. Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, 3rd ed. v. 1, St. Louis: Mosby, 1997;52-70.
4. Ciardella AP, Guyer DR, Spitznas M, Yannuzzi LA. Central Serous Chorioretinopathy. In: Ryan S, ed. Retina. Vol.2. St Louis: Mosby, 2001;1153-81.
5. Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc 1986;84:799-845.
6. Chumbley LC, Frank RN. Central serous retinopathy and pregnancy. Am J Ophthalmol 1974;77:158-60.
7. Jain IS, Singh K. Maculopathy a corticosteroid side-effect. J All India Ophthalmol Soc 1966;14:250-2.
8. Bouzas EA, Scott MH, Mastorakos G, et al. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 1993;111:1229-33.
9. Thoelen AM, Bernasconi PP, Schmid C, Messmer EP. Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. Retina 2000;20:98-9.
10. Brown MA, Cramp HA, Zammit VC, Whitworth JA. Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'? Aust N Z J Med 1996;26:533-8.
11. Mosso L, Fardella C, Montero J, et al. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension]. Rev Med Chil 1999;127:800-6.
12. Tittl MK, Spaide RF, Wong D, et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999;128:63-8.
13. Goldstein DS. Plasma catecholamines and essential hypertension. An analytical review. Hypertension 1983;5:86-99.
14. Koss MC, Gherezghiher T. Adrenoceptor subtypes involved in neurally evoked sympathetic vasoconstriction in the anterior choroid of cats. Exp Eye Res 1993;57:441-7.
15. Sibayan SA, Kobuch K, Spiegel D, et al. Epinephrine, but not dexamethasone, induces apoptosis in retinal pigment epithelium cells in vitro: possible implications on the pathogenesis of central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2000;238:515-9.
16. Hadcock JR, Malbon CC. Regulation of beta-adrenergic receptors by "permissive" hormones: glucocorticoids increase steady-state levels of receptor mRNA. Proc Natl Acad Sci U S A 1988;85:8415-9.
17. Sakaue M, Hoffman BB. Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTTI MF-2 smooth muscle cells. J Clin Invest 1991;88:385-9.
18. Grassby PF, McNeill JH. Hyperthyroidism induces supersensitivity to biogenic amines in rat vascular tissue via a pre- and a postjunctional mechanism. J Pharmacol Exp Ther 1988;244:1027-35.
19. Garg SP, Dada T, Talwar D, Biswas NR. Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol 1997;81:962-4.
20. Wakakura M, Suzuki H. Urinary excretion of catecholamines in central serous chorioretinopathy. Jpn J Clin Ophthalmol 1979;33:1237-40.
21. Spaide RF, Campeas L, Haas A, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology 1996;103:2070-9; discussion 2079-80.
22. Spaide RF, Hall L, Haas A, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996;16:203-13.
23. Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987;325:253-7.
24. Arndt C, Sari A, Ferre M, et al. Electrophysiological effects of corticosteroids on the retinal pigment epithelium. Invest Ophthalmol Vis Sci 2001;42:472-5.
25. Dohrmann J, Lommatzsch A, Spital G, Pauleikhoff D. [Pathogenesis of central serous chorioretinopathy: angiographic and electrophysiological studies]. Ophthalmologe 2001;98:1069-73.
26. Chappelow AV, Marmor MF. Multifocal electroretinogram abnormalities persist following resolution of central serous chorioretinopathy. Arch Ophthalmol 2000;118:1211-5.
27. Yard AC, Kadowitz PJ. Studies on the mechanism of hydrocortisone potentiation of vasoconstrictor responses to epinephrine in the anesthetized animal. Eur J Pharmacol 1972;20:1-9.
28. Yannuzzi LA. Type-A behavior and central serous chorioretinopathy. Retina 1987;7:111-31.
29. Williams RB, Jr, Lane JD, Kuhn CM, et al. Type A behavior and elevated physiological and neuroendocrine responses to cognitive tasks. Science 1982;218:483-5.
30. Friedman M, Byers SO, Diamant J, Rosenman RH. Plasma catecholamine response of coronary-prone subjects (type A) to a specific challenge. Metabolism 1975;24:205-10.
31. Quinn RH, Quong JN, Miller SS. Adrenergic receptor activated ion transport in human fetal retinal pigment epithelium. Invest Ophthalmol Vis Sci 2001;42:255-64.
32. Joseph DP, Miller SS. Alpha-1-adrenergic modulation of K and C1 transport in bovine retinal pigment epithelium. J Gen Physiol 1992;99:263-90.
33. Hassan L, Carvalho C, Yannuzzi LA, et al. Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine (MDMA) or "ecstasy." Retina 2001;21:559-61.
34. Yoshioka H, Katsume Y, Akune H. Experimental central serous chorioretinopathy. I: Clinical findings. Jpn J Ophthalmol 1981;25:112-18.
35. Yoshioka H, Katsume Y, Akune H. Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings. Ophthalmologica 1982;185:168-78.
36. Yoshioka H, Katsume Y, Ishibashi R. Experimental central serous chorioretinopathy. II: Further clinical findings. Kurume Med J 1981;28:189-96.
37. Goncharov NP, Katsiia GV, Shekhova AN. [Circadian rhythm of corticosteroids in female hamadryas baboons during long-term hypokinesia]. Probl Endokrinol (Mosk) 1985;31:70-3.
38. Gauquelin-Koch G, Blanquie JP, Viso M, et al. Hormonal response to restraint in rhesus monkeys. J Med Primatol 1996;25:387-96.
39. Aguilera G, Kiss A, Sunar-Akbasak B. Hyperreninemic hypoaldosteronism after chronic stress in the rat. J Clin Invest 1995;96:1512-9.
40. Markov KhM, Bankova VV, Kucherenko AG. [Biosynthesis and metabolism of aldosterone under conditions of neurogenic stress]. Probl Endokrinol (Mosk) 1978;24:113-8.
41. Fatti LM, Bottasso B, Invitti C, et al. Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. J Endocrinol Invest 2000;23:145-50.
42. Brown NJ, Nakamura S, Ma L, et al. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney Int 2000;58:1219-27.
43. Yamada R, Yamada S, Ishii A, Tane S. [Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy]. Nippon Ganka Gakkai Zasshi 1993;97:955-60.
44. Gass JD. Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol 1991;109:677-81.
45. Kruithof EK, Tran-Thang C, Gudinchet A, et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 1987;69:460-6.
46. Small M, Kluft C, MacCuish AC, Lowe GD. Tissue plasminogen activator inhibition in diabetes mellitus. Diabetes Care 1989;12:655-8.
47. Bruzdzinski CJ, Johnson MR, Goble CA, et al. Mechanism of glucocorticoid induction of the rat plasminogen activator inhibitor-1 gene in HTC rat hepatoma cells: identification of cis-acting regulatory elements. Mol Endocrinol 1993;7:1169-77.
48. Krishnamurti C, Tang DB, Barr CF, Alving BM. Plasminogen activator and plasminogen activator inhibitor activities in a reference population. Am J Clin Pathol 1988;89:747-52.
49. Grandaliano G, Di Paolo S, Monno R, et al. Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and fibrinolysis in renal graft fibrosis. Transplantation 2001;72:1437-43.
50. Hayashi K, Hasegawa Y, Tokoro T. Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol 1986;9:37-41.
51. Scheider A, Nasemann JE, Lund OE. Fluorescein and indocyanine green angiographies of central serous choroidopathy by scanning laser ophthalmoscopy. Am J Ophthalmol 1993;115:50-6.
52. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996;121:26-34.
53. Birchall W, Charles SJ, Buckler HM. Cyclical central serous chorloretinopathy associated with cystoid macular oedema [letter]. Br J Ophthalmol 2001;85:756-8.
54. Perkins SL, Kim JE, Pollack JS, Merrill PT. Clinical characteristics of central serous chorioretinopathy in women. Ophthalmology 2002;109:262-6.
55. Gudmundsson A, Goodman B, Lent S, et al. Effects of estrogen replacement therapy on the circadian rhythms of serum cortisol and body temperature in postmenopausal women. Exp Gerontol 1999;34:809-18.
56. Corda D, Kohn LD. Thyrotropin upregulates alpha 1-adrenergic receptors in rat FRTL-5 thyroid cells. Proc Natl Acad Sci U S A 1985;82:8677-80.
57. Das DK, Bandyopadhyay D, Bandyopadhyay S, Neogi A. Thyroid hormone regulation of beta-adrenergic receptors and catecholamine sensitive adenylate cyclase in foetal heart. Acta Endocrinol (Copenh) 1984;106:569-76.
58. Haimovici R, Gragoudas ES, Duker JS, et al. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology 1997;104:1653-60.
59. Cassel GH, Brown GC, Annesley WH. Central serous choriorefinopathy: a seasonal variation? Br J Ophthalmol 1984;68:724-6.
60. Haimovici R, Koh S, Gagnon DR, et al. Risk factors for central serous chorioretinopathy: a case-control study. In publication.
61. Hasegawa M, Saito Y, Naka F, Kiyoi M. Seasonal variations of total histamine in patients with seasonal allergic rhinitis. Clin Allergy 1983;13:277-86.